Advertisement

Infectious Disease

Home Infectious Disease

FDA Could Approve Pfizer Booster Shots for All Adults This Week

More than 30 million Americans have already gotten booster shots

Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries

Countries included in licensing deal mostly in Africa and Asia and account for more than half of the world's population

Progress Made in Reducing Depression During Internship

Increases in sleep hours and use of mental health services, decrease in work hours occurred in parallel to decrease in depressive symptoms

Flu Vaccine Coverage Suboptimal for Medicare Beneficiaries

Uptake of vaccination higher among beneficiaries with versus without high-risk conditions; missed opportunities for vaccination are common

9.6 Percent of People of All Ages Uninsured in First Half of 2021

Among adults aged 18 to 64 years, 14.0 percent were uninsured, 21.6 percent had public coverage, 66.3 percent had private health coverage

Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds

BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups

Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill

Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness

CDC Warns of E. Coli Outbreak Linked to Baby Spinach

Illness reported in Indiana, Iowa, Michigan, Minnesota, Missouri, Ohio, South Dakota; two hospitalizations but no deaths reported

Salmonella Outbreak Linked to Salami Sticks Rises to 31 Cases in 10 States

There have been six hospitalizations reported, but no deaths

ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines

However, overall disease activity does not appear to change after vaccination